These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12962873)

  • 1. Neither acute rejection nor immunosuppressant drug therapy (cyclosporine or tacrolimus) correlates with expression of either CD40 or CD154 on peripheral blood cells among human cardiac transplant patients.
    Domenech N; Crespo-Leiro MG; Moscoso I; Paniagua MJ; Naya C; Muñiz J; Vazquez-Rodriguez JM; Castro-Beiras A
    Transplant Proc; 2003 Aug; 35(5):1994-5. PubMed ID: 12962873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
    Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
    J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation.
    van Rijen MM; Kuijf ML; Metselaar HJ; Tilanus HW; Bouma GJ; de Weger RA; Jonker M; Kwekkeboom J
    Transplantation; 2002 May; 73(10):1666-72. PubMed ID: 12042657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
    Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection.
    Reul RM; Fang JC; Denton MD; Geehan C; Long C; Mitchell RN; Ganz P; Briscoe DM
    Transplantation; 1997 Dec; 64(12):1765-74. PubMed ID: 9422418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection.
    Shoker A; George D; Yang H; Baltzan M
    Transplantation; 2000 Aug; 70(3):497-505. PubMed ID: 10949194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection.
    Schowengerdt KO; Fricker FJ; Bahjat KS; Kuntz ST
    Transplantation; 2000 May; 69(10):2102-7. PubMed ID: 10852605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus as a rescue immunosuppressant after heart transplantation.
    De Bonis M; Reynolds L; Barros J; Madden BP
    Eur J Cardiothorac Surg; 2001 May; 19(5):690-5. PubMed ID: 11343954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection.
    Yamani MH; Starling RC; Goormastic M; Van Lente F; Smedira N; McCarthy P; Young JB
    Transplantation; 2000 Jun; 69(11):2326-30. PubMed ID: 10868634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole blood genomic biomarkers of acute cardiac allograft rejection.
    Lin D; Hollander Z; Ng RT; Imai C; Ignaszewski A; Balshaw R; Freue GC; Wilson-McManus JE; Qasimi P; Meredith A; Mui A; Triche T; McMaster R; Keown PA; McManus BM; ;
    J Heart Lung Transplant; 2009 Sep; 28(9):927-35. PubMed ID: 19716046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dendritic cells in the context of acute cellular rejection: comparison between tacrolimus- or cyclosporine A-treated heart transplanted recipients.
    John K; Dieterlen MT; Tarnok A; Garbade J; Bittner HB; Mohr FW; Barten MJ
    Cytometry B Clin Cytom; 2014 Sep; 86(5):362-7. PubMed ID: 24668729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A.
    Behr TM; Richter K; Fischer P; Spes CH; Meiser B; Reichart B; Pongratz D; Feucht H; Theisen K; Angermann CE
    Transplant Proc; 1998 Aug; 30(5):1920-1. PubMed ID: 9723333
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation.
    Li W; Lu L; Li Y; Fu F; Fung JJ; Thomson AW; Qian S
    Transplant Proc; 1997; 29(1-2):1081-2. PubMed ID: 9123209
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation.
    Branco KC; Azeka E; Trindade E; Galas FR; Hajjar LA; Benvenuti L; Riso A; Tanamati C; Penha J; Auler JO; Jatene M
    Transplant Proc; 2012 Oct; 44(8):2483-5. PubMed ID: 23026625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.
    Sgrosso JL; Ferrer J; Araujo G; Romeo L; Parisi C; Vázquez MC
    Transplant Proc; 2002 Feb; 34(1):115-6. PubMed ID: 11959214
    [No Abstract]   [Full Text] [Related]  

  • 17. CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection.
    Gaweco AS; Mitchell BL; Lucas BA; McClatchey KD; Van Thiel DH
    Kidney Int; 1999 Apr; 55(4):1543-52. PubMed ID: 10201021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.
    Solez K; Vincenti F; Filo RS
    Transplantation; 1998 Dec; 66(12):1736-40. PubMed ID: 9884269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HLA molecules on peripheral blood lymphocytes: a useful monitoring parameter in cardiac transplantation.
    Blanco-Garcia RM; López-Alvarez MR; Pascual-Figal DA; Polo-Garcia L; Guerra N; Campillo JA; Muro M; Garcia-Alonso AM; Marin-Moreno I; Valdes M; Alvarez-López MR; Minguela A
    Transplant Proc; 2007 Sep; 39(7):2362-4. PubMed ID: 17889190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central role for CD40/CD40 ligand (CD154) interactions in transplant rejection.
    Denton MD; Reul RM; Dharnidharka VR; Fang JC; Ganz P; Briscoe DM
    Pediatr Transplant; 1998 Feb; 2(1):6-15. PubMed ID: 10084754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.